A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2018.01.011
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Elsevier BV